Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

WuXi PharmaTech (Cayman) Inc (NYSE:WX)

Delayed Data
As of Nov 24
 +0.19 / +0.42%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Wuxi PharmaTech (Cayman), Inc. is engaged in the provision of research and development outsourcing services for the pharmaceutical, biotechnology, and medical device industries. It operates through the Laboratory Services and Manufacturing Services segments. The Laboratory Services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The Manufacturing Services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang, and Ning Zhao in 2000 and is headquartered in Shanghai, China.

Contact Information

Wuxi PharmaTech (Cayman) Inc.
288 Fute Zhong Road
Shanghai Shanghai 200131
Investor Relations:
(201) 585-2048



Mutual fund holders44.14%
Other institutional39.83%
Individual stakeholders--

Top Executives

Ge LiChairman & Chief Executive Officer
Steve YangChief Operating Officer & Executive Vice President
Edward HuChief Financial & Investment Officer
Shu Hui ChenChief Scientific Officer
Xiao Zhong LiuDirector & Executive Vice President